Abstract
e21027 Background: Estrogen receptors (ER) and invasive protease such as urokinase-type plasminogen activator (uPA), its inhibitor plasminogen activator inhibitor type 1 (PAI-1), cathepsin D (CathD), and thymidine kinase (TK) are known prognostic factors in breast cancer (BC). The advantage of using combination of these proteases to ER to identify BC subsets of differential prognosis was evaluated. Methods: Analysis of a prospective collected clinical database. uPA, PAI-1, CathD, and TK levels were prospectively measured by enzyme-linked immunosorbent assay in tumor tissue extracts of 316 patients with primary BC treated surgically. Distribution and relation between these factors and ER were analyzed. Survival outcome according to identified BC profiles were compared. Results: The levels between ER and PAI-1 were inversely correlated (r = -0.17, p = 0.003). Similar observation was made between ER levels and uPA (r = -0.14, p = 0. 01). The quantitative values of ER were not significantly correlated with TK...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
